A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine ...
Apr 21, 2020
1
4555
Most people who get COVID-19 recover within a few weeks. But some people—even those who had mild versions of the disease—have symptoms that last weeks or months after an initial COVID infection. These ongoing health problems, ...
Oct 12, 2022
0
116
Led by Charité – Universitätsmedizin Berlin, researchers from 31 European clinical institutions, including a team from the University of Glasgow, worked together as part of the DISCHARGE trial. The aim of the trial was ...
Mar 15, 2022
0
179
Despite having benefits for information exchange and patient safety, electronic health records (EHR) have had drawbacks for daily practice and the physician experience. Some studies suggest that physicians practicing in solo ...
Apr 21, 2022
0
29
When and where are often vital clues for epidemiologists, the medical detectives who help solve the underlying mysteries of disease. The technique dates back to at least 19th century London, where a physician named John Snow ...
Jan 12, 2023
0
6
A small team of researchers with members from Case Western Reserve University School of Medicine and the MetroHealth System has found a link between children who contract COVID-19 and an increased risk of developing type ...
Elementary school-age children who get less than nine hours of sleep per night have significant differences in certain brain regions responsible for memory, intelligence and well-being compared to those who get the recommended ...
Jul 29, 2022
1
1043
People with HIV have a higher rate of breakthrough COVID-19 infections after vaccination, compared to people without HIV, according to findings from a study led by researchers at the Johns Hopkins Bloomberg School of Public ...
Jun 7, 2022
0
8
According to an accepted manuscript published in ARRS' American Journal of Roentgenology (AJR), axillary lymphadenopathy after a COVID-19 vaccine booster dose has a mean time to resolution of 102 days, shorter than the time ...
Mar 9, 2023
0
35
About 10% of the population in high income regions like Europe and the United States has been diagnosed with one or multiple autoimmune disorders. Examples are rheumatoid arthritis, psoriasis, systemic sclerosis, lupus erythematosus ...
Aug 27, 2022
0
175
